Investigating how specific glycine receptors affect visual processing in the retina
Glycine subunit specific inhibition and ganglion cell visual responses
This study is looking at how certain proteins in eye cells help us see and understand things like motion and color, and it could lead to new ways to help people with vision problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10622520 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of glycine receptor subunits in retinal ganglion cells, which are crucial for processing visual information. By examining how these receptors influence the integration of excitatory and inhibitory signals, the study aims to uncover the mechanisms behind our perception of motion, color, and spatial relationships in our visual field. The approach involves advanced techniques such as pharmacological interventions and biophysical measurements to analyze the responses of these cells. Patients may benefit from insights gained into visual processing disorders and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with visual processing disorders or those experiencing difficulties with motion perception.
Not a fit: Patients with purely structural eye conditions unrelated to synaptic function may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for visual processing disorders, enhancing patients' quality of life.
How similar studies have performed: While the specific focus on glycine receptor subunits in retinal ganglion cells is novel, similar research has shown promise in understanding neurotransmitter roles in visual processing.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Mccall, Maureen a — University of Louisville
- Study coordinator: Mccall, Maureen a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.